Actividades asistenciales

4 - IMIDAZOPYRIDAZIN- 1 -YL-BENZAMIDES AND 4 - IMIDAZOTRIAZIN- 1 - YL - BENZAMIDES AS BTK- INHIBITORS
30/04/2025 - The present invention relates to 6-5 membered fused pyridine ring compounds according to formula (I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising...
EFFICIENT CACHING FOR RADIOTHERAPY OBJECT VISUALIZATION AND PROCESSING
01/05/2025 - Systems and techniques may be used for visualization of radiation therapy data. An example method may include determining a data set corresponding to visualization data to be displayed in an...
SCINTILLATOR, POWDERS HAVING SCINTILLATORS, SUSPENSION HAVING SCINTILLATORS AND METHOD OF FORMING SCINTILLATORS
01/05/2025 - There is described a scintillator for electromagnetic radiation therapy comprising a nanotube being functionalized with a plurality of singlet oxygen photosensitizers configured to form singlet...
Immunogenic mutant peptide screening platform
01/05/2025 - The present disclosure provides methods of identifying a disease-specific immunogenic peptide through a series of selection steps. Immunogenic epitopes identified by methods of the present...
BIFUNCTIONAL COMPOUNDS CONTAINING 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY
01/05/2025 - The present disclosure provides certain bifunctional compounds that cause degradation of Cyclin-dependent kinase 2 (CDK2) via ubiquitin proteasome pathway and are therefore useful for the...
COMBINATION OF A TYROSINE KINASE INHIBITOR AND A PRO-INFLAMMATORY AGENT FOR TREATING CANCER
01/05/2025 - The present application provides methods of treating a cancer in an individual that involves administering to the individual a tyrosine kinase inhibitor and a pro-inflammatory agent (such as a TLR...
Composition
01/05/2025 - The present invention provides a pharmaceutical composition comprising a peroxisome proliferator activated receptor (PPAR) modulator and an polymeric nanocarrier component, wherein the polymeric...
HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS
28/04/2025 - La presente invención se refiere a compuestos de fórmula general (I) que inhiben la familia JAK de tirosina proteína cinasas no receptoras (JAK1, JAK2, JAK3 y TYK2); métodos para preparar...
Novel therapeutic agent for Parkinson's disease
02/04/2025 - 본 출원은 신규한 파킨슨 병 치료제 및 이를 이용하는 파킨슨 병의 치료 방법에 관한 것이다.